SCHEMBL13209552

SCHEMBL13209552

COC[C@H](C)Oc1cc(O)cc(C(=O)NC(=N)/C=C\NC(=O)OC(C)(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GCK P35557 19/20 0.38
RARA P10276 1/20 0.36
RARB P10826 1/20 0.36
RARG P13631 1/20 0.35
GRM5 P41594 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13209565 0.87 GCK (0.46) GCKRARARARBRARG
SCHEMBL13209323 0.86 GCK (0.42) GCKRARARARBRARGGRM5
SCHEMBL13209296 0.86 GCK (0.42) GCKRARARARBRARGGRM5
SCHEMBL2667101 0.77 GCK (0.40) GCKRARARARBRARGGRM5
SCHEMBL13209318 0.76 GCK (0.34) GCK
SCHEMBL13209292 0.76 GCK (0.33) GCKRARARARBRARG
SCHEMBL2666549 0.75 GCK (0.38) GCK
SCHEMBL2666257 0.74 GCK (0.45) GCKRARARARBRARG
SCHEMBL13209325 0.72 GCK (0.51) GCKRARARARBRARG
SCHEMBL13209586 0.71 GCK (0.51) GCKRARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756076-B1 HETROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2010-08-11 EP disclosed